Medicare hospice is often described as a no-cost benefit, yet two targeted charges remain inside it. A patient can owe up to $5 for each outpatient prescription used for pain or symptom management, while short inpatient respite care can require 5% of the Medicare-approved amount. Those numbers are limited compared with the cost of the full hospice team, but they reveal the benefit’s design: Medicare removes most treatment-related bills while preserving narrow cost sharing for drugs and temporary caregiver relief.
Hospice Election Moves Care Into a New Payment System
Part A covers hospice when doctors certify a terminal illness with a life expectancy of six months or less if the disease follows its normal course, and the patient elects comfort care rather than treatment intended to cure the terminal condition. Medicare’s official hospice page says covered services from an approved provider generally cost the patient nothing. Medicare pays the hospice organization, which coordinates the team, equipment, counseling, nursing, and drugs connected to the terminal illness.
The hospice election framework is not a surrender of all Medicare coverage. Original Medicare continues to cover care for health problems unrelated to the terminal illness under the usual deductibles and coinsurance. The hospice benefit ordinarily becomes responsible for services related to the terminal condition and associated symptoms. That dividing line is central to billing because a drug treated as unrelated may move to Part D or another benefit, while a related drug belongs inside the hospice arrangement.
Hospice runs through two initial 90-day benefit periods followed by an unlimited number of 60-day periods, provided the patient is recertified as terminally ill. The six-month prognosis is an eligibility judgment, not a hard coverage expiration. A patient can remain in hospice beyond six months when the medical certification continues, and can revoke the election or change hospice providers within Medicare’s rules.
Free retirement updates: Social Security and Medicare change every year, and nobody sends you a memo. The free Retirement Shield newsletter breaks down what changed and what to do. Get it free in your inbox.
The $5 and 5% Charges Cover Different Needs
The prescription charge is a copayment of no more than $5 for each outpatient drug used for pain and symptom control. It is not a monthly pharmacy fee or a percentage of the drug’s list price. When a drug is related to the terminal illness, the hospice generally supplies or arranges it under the hospice benefit. If the hospice says a medication is unrelated, it must explain that determination, and the patient’s Part D plan may then become relevant.
Respite care addresses the caregiver rather than a change in the patient’s prognosis. The hospice can arrange a short inpatient stay so a family caregiver can rest, during which the patient may owe 5% of the Medicare-approved amount. Medicare limits the patient share so it cannot exceed the inpatient hospital deductible for a respite stay. The federal hospice benefits booklet explains how respite fits alongside routine home care, continuous home care, and general inpatient care.
Room and board is a separate exposure. Medicare generally does not pay ordinary residence costs when a patient lives in a nursing home or hospice facility, even though the hospice team and related clinical services may be covered. General inpatient care arranged because symptoms cannot be managed elsewhere is different from choosing a facility as a place to live. Confusing those settings can turn a largely covered clinical benefit into an unexpected private-pay housing bill.
Caregiver relief also has a defined shape. Respite is short-term inpatient care arranged by the hospice, not a general reimbursement for a family to book a facility whenever help is unavailable. Because the hospice coordinates the placement and Medicare-approved amount, going around the team can change both coverage and cost. The 5% share attaches to covered respite, not to every temporary residential stay. Its purpose is a brief break for the caregiver while the hospice remains responsible for the patient’s plan.
The Provider’s Relatedness Decision Controls Many Disputes
A patient may request a written list of items, services, and drugs the hospice has determined are unrelated to the terminal illness and related conditions, including the reason for each decision. That list gives families something more concrete than a pharmacy rejection. It also matters to outside clinicians, because care obtained without coordination can fall outside the hospice payment arrangement and leave the patient exposed.
Hospice providers receive daily payments under a federal system described by the Centers for Medicare & Medicaid Services in its Medicare payment-systems guide. The bundled structure is why the provider, not the patient, ordinarily manages the cost of related drugs and services. It is also why a provider should arrange any hospital stay needed for symptom management; an uncoordinated admission can create a dispute over whether hospice should have supplied the care.
The two visible copayments are therefore not the whole financial story. Five dollars belongs to related outpatient symptom drugs, and 5% belongs to short inpatient respite, while room, board, unrelated treatment, and uncoordinated services follow other rules. Medicare’s hospice benefit is broadest when the care team controls the related services as a single package. The written election and the provider’s relatedness list define the edges where household costs reappear.
This article was produced with AI assistance and reviewed by The Money Overview editorial team.
More Financial Reading
